[1]
de Almeida Junior, J., Girelli Neto, S., Daiane Nobre Sampaio Chagas, C., Julia Oliveira Caldeira Horing, M., Vieira Donzelli, R., Alves Coelho Neto, M., Emanuelli Seganfredo, J., Aparecida Medeiros Manca, J., José Paludo Petek, D. and José Bordin da Silva, W. 2024. Medication change, from Natalizumab to Ocrelizumab, in a patient with relapsing-remitting multiple sclerosis: case report. Brazilian Journal of Implantology and Health Sciences . 6, 10 (Oct. 2024), 574–584. DOI:https://doi.org/10.36557/2674-8169.2024v6n10p574-584.